HGA
NVO

Hobbs Group Advisors’s Novo Nordisk NVO Stock Holding History

Hobbs Group Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,378
Closed -$302K – 162
2025
Q2 		$302K Sell
4,378
-382
-8% -$26K 0.1% 127
2025
Q1 		$331K Sell
4,760
-4,766
-50% -$394K 0.13% 114
2024
Q4 		$819K Sell
9,526
-2,968
-24% -$321K 0.31% 65
2024
Q3 		$1.49M Sell
12,494
-418
-3% -$55.7K 0.53% 31
2024
Q2 		$1.84M Buy
+12,912
New +$1.71M 0.7% 28
2023
Q4 		$329K Buy
+3,178
New +$314K 0.15% 98

Other funds holding NVO

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Hobbs Group Advisors's NVO Position: Q3 2025 in Review

Hobbs Group Advisors sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 4,378 shares — an estimated $302K sold.

Hobbs Group Advisors first reported a position in NVO in Q4 2023 and held it in 6 quarters. The position peaked at $1.84M in Q2 2024. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Hobbs Group Advisors reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • Hobbs Group Advisors sold 4,378 Novo Nordisk shares in Q3 2025, an estimated $302K.
  • Hobbs Group Advisors first reported a position in Novo Nordisk in Q4 2023 and held it in 6 quarters.
  • Hobbs Group Advisors's Novo Nordisk position peaked at $1.84M in Q2 2024.
  • 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Hobbs Group Advisors's 13F filing for Q3 2025, filed 13 Nov 2025.